Abstract-Hypertension is very prevalent in chronic kidney disease and critical for its prognosis. Sympathoexcitation and oxidative stress have been demonstrated to be involved in chronic kidney disease. We have shown previously that sympathoexcitation by brain oxidative stress mediates arterial pressure elevation in the salt-sensitive hypertension model, Dahl salt-sensitive rats. Thus, we investigated whether sympathoexcitation by excessive brain oxidative stress could contribute to arterial pressure elevation in salt-induced chronic kidney disease model rats. Young (3-week-old) male Sprague-Dawley rats were randomly assigned to a uninephrectomy or sham operation and then subjected to either a normal salt (0.5%) or high-salt (8.0%) diet for 4 weeks. The young salt-loaded uninephrectomized rats exhibited sympathoexcitation, hypertension, and renal injury, proteinuria and global glomerulosclerosis together with tubulointerstitial damage. Under urethane anesthesia and artificial ventilation, renal sympathetic nerve activity, arterial pressure, and heart rate decreased to a greater degree in the salt-loaded uninephrectomized rats than in the nonsalt-loaded uninephrectomized rats and the salt-loaded or nonsalt-loaded sham-operated rats, when Tempol, a membrane-permeable superoxide dismutase mimetic, was infused acutely into the lateral cerebral ventricle. Oxidative stress in the hypothalamus, measured by lucigenin chemiluminescence, was also significantly greater. Furthermore, in the salt-loaded uninephrectomized rats, antioxidant treatment with chronic intracerebroventricular Tempol decreased sympathetic nerve activity and arterial pressure, which, in turn, led to a decrease in renal damage. Similar effects were elicited by treatment with oral moxonidine, the central sympatholytic agent. In conclusion, sympathoexcitation by brain oxidative stress may mediate arterial pressure elevation in salt-induced chronic kidney disease. (Hypertension. 2012; 59:00-00.) • Online Data Supplement
H ypertension is very prevalent in chronic kidney disease (CKD) and contributes strongly to its progression. Sympathetic activation has been demonstrated to play an important role in the pathogenesis of hypertension associated with CKD. 1, 2 Clinical studies have demonstrated that plasma catecholamines were elevated 3 and muscle sympathetic nerve activity was enhanced 4, 5 in CKD patients, whose blood pressure decreased pronouncedly with adrenergic inhibition by clonidine. 6 Furthermore, moxonidine, a central sympatholytic agent, was shown to reduce urinary albumin excretion associated with huge depressor effects in patients with essential hypertension with microalbuminuria. 7 In fact, renal denervation ameliorated hypertension in various animal models 8 including ours. 9 Recently, catheter-based renal denervation safely reduced blood pressure in patients with treatment-resistant hypertension. 10 The renal nerves consist of afferent and efferent signals. Although both of them are important in the pathophysiology of hypertension, 11 the renal afferent nerve has been suggested to contribute to sympathetic activation and the resultant hypertension in the diseased kidney. 1, [12] [13] [14] Afferent renal denervation prevented the development of hypertension in 5/6 nephrectomized rats. 12 Renal injury may activate afferent pathways connecting with brain regions involved in the control of blood pressure. Afferent renal nerves play an essential and obligatory role in the normal renal adaptive response to oral salt loading under physiological conditions. 15 On the other hand, in the pathophysiological conditions, the impairment of the renorenal reflex leads to salt-induced arterial pressure elevation. 16 However, what happens in the brain to cause sympathoexcitation in CKD patients has not been fully explained.
In our previous report, 17 salt loading enhanced a rise in arterial pressure that was induced by central sympathoexcitation, possibly through the overproduction of brain reactive oxygen species (ROS), in an animal model of increased oxidative stress. We have also shown that increased oxidative stress in the brain elevated arterial pressure, possibly through central sympathoexcitation, in a salt-sensitive hypertension model, Dahl salt-sensitive rats, 18 and in an obesity-induced hypertension model, high-fat diet-fed rats, 19 in both of which systemic ROS overproduction has been reported. 20, 21 Similarly, increased oxidative stress has also been reported in CKD. [22] [23] [24] Actually, salt-sensitive hypertension 25 and obesity 26 are associated with abnormal salt handling in the kidney and an increased risk of the development of CKD. Recently, central sympathetic activation has been reported to be mediated by brain ROS in the phenol renal injury model of hypertension 27 and in the 2-kidney, 1-clip hypertension model. 28 Thus, brain ROS overproduction might be a characteristic of hypertension associated with renal dysfunction. Therefore, we hypothesized that central sympathetic activation, possibly because of the overproduction of oxidative stress in the brain, could contribute to arterial pressure elevation in salt-induced CKD.
In the present study, to clarify our hypothesis, we examined the following points by using young, salt-loaded, uninephrectomized Sprague-Dawley rats 29, 30 as a salt-induced CKD model. We evaluated the responses of renal sympathetic nerve activity (RSNA) and arterial pressure to acute intracerebroventricular (ICV) administration of an antioxidant agent, Tempol, and the level of ROS in the hypothalamus. In our previous reports, [17] [18] [19] we showed the effects of acute ICV Tempol but did not show the effects of chronic ICV Tempol. Thus, our previous data only suggested a pathophysiological role of brain ROS but did not show the usefulness of central antioxidant treatment. Therefore, we elucidated whether chronic ICV Tempol could recover sympathetic nerve activity and arterial pressure.
Methods Animals
Three-week-old male Sprague-Dawley rats (Tokyo Laboratory Animals Science, Tokyo, Japan) were randomly assigned to a uninephrectomy or sham operation and then subjected to either a normalsalt (0.5%) or high-salt (8.0%) diet for 4 weeks. In addition, the salt-loaded uninephrectomized rats were treated with moxonidine (1.5 mg/kg per day orally), 31 a central sympatholytic agent, for 4 weeks, to investigate the role of sympathetic nerve activity in arterial pressure elevation in salt-induced CKD. Moreover, to investigate the role of brain ROS, ICV administration of Tempol was continued for 4 weeks in the salt-loaded uninephrectomized rats. In this way, 6 different experimental groups were created: sham-operated rats raised with a normal (sham) or high-salt diet (shamϩHS), uninephrectomized rats raised with a normal (Unx) or high-salt diet (UnxϩHS), 29, 30 moxonidine-treated UnxϩHS rats (UnxϩHSϩMox), and chronic ICV Tempol-treated UnxϩHS rats (UnxϩHSϩICV temp).
Either a unilateral nephrectomy or a sham operation was performed on 3-week-old Sprague-Dawley rats anesthetized with sodium pentobarbital (40 mg/kg IP) in the same way as that described previously. 32 For the continuous and ICV administration of Tempol in 3-week-old rats anesthetized with sodium pentobarbital (40 mg/kg IP), after uninephrectomy, cannulae were fixed to the cranium using small screws and dental cement and were connected by silastic tubing to osmotic minipumps (0.5 L/h, ALZET Osmotic Pump, model 2002) implanted subcutaneously at the back of the neck. The cannulae and osmotic minipumps were replaced by new ones after 2 weeks of salt loading. Tempol (25 g in 0.5 L/h) 33 dissolved in artificial cerebrospinal fluid (ACSF; in millimoles per liter: NaCl, 123.00; CaC1 2 , 0.86; KCI, 3.00; MgCl 2 , 0.89; NaHCO 3 , 25.00; NaH 2 PO 4 , 0.50; Na 2 HPO 4 , 0.25) was infused into the lateral cerebral ventricles of the UnxϩHS rats by the osmotic minipumps for 4 weeks. The accuracy of the ICV injection was confirmed by injecting Evans blue dye after the animals were euthanized. Moreover, ICV vehicle (ACSF) infusion was performed to confirm the effect of ICV infusion itself in the other UnxϩHS rats. To rule out the peripheral effect of Tempol, the same dose of Tempol (25 g in 0.5 L/h) dissolved in saline was also infused intraperitoneally by the osmotic minipumps for 4 weeks in additional UnxϩHS rats.
All of the rats were housed in a room maintained at 23°C to 25°C with a 12-hour light/dark cycle and were given food and water ad libitum. All of the experimental procedures were approved by the ethics committees on animal research of the Faculty of Medicine, University of Tokyo.
Evaluation of Blood Pressure and Systemic Sympathetic Nerve Activity
Systolic blood pressure (SBP) was measured by the tail-cuff method (P-98A; Softron, Tokyo, Japan). In some unrestrained conscious rats, the arterial pressure was directly measured. The femoral artery and vein were cannulated under ether anesthesia. Mean arterial pressure (MAP) was recorded in the conscious state after waiting for 3 hours for recovery from anesthesia, as described previously. [17] [18] [19] After the baseline MAP measurement, the response of the MAP to a ganglionic blockade was examined by injecting IV 30 mg/kg of body weight of hexamethonium hydrochloride, to evaluate systemic sympathetic nerve activity. The maximal decrease in the MAP was considered as an index of sympathetic activity. 32 
Acute ICV Administration of Tempol
In urethane-anesthetized (1 g/kg) and artificially ventilated rats, the MAP, heart rate (HR), and RSNA were recorded, as mentioned in our previous reports. [17] [18] [19] 34 The distal ends of real nerves were cut to measure their efferent discharge. For detailed methods about how to record RSNA, please see the online Data Supplement (available at http://hyper.ahajournals.org). After recording the basal MAP, HR, and RSNA during a 30-minute stabilization period, Tempol (20 mol in 10 L) dissolved in ACSF or vehicle (ACSF) was infused into the lateral ventricle for 10 minutes, and changes in the parameters were recorded. The dose of Tempol was determined as described previously. [17] [18] [19] 35 The accuracy of the ICV injection was confirmed by injecting Evans blue dye after each experiment.
Measurement of NADPH-Induced Superoxide Production in the Isolated Hypothalamus
The production of superoxide anions induced by NADPH (final concentration: 100 mol/L) was measured by bis-N-methylacridinium (lucigenin) chemiluminescence in the isolated hypothalamus, where several nuclei critically involved in cardiovascular regulation are known to be located, 36 as described previously. 18, 19, 37 
Urinary Protein Excretion and Renal Histology
We measured urinary protein excretion using the pyrogallol red method after 4 weeks of dietary treatment. For morphological evaluations, paraffinized kidney sections (3-m thickness) were stained with periodic acid-Schiff reagents and analyzed semiquantitatively for glomerulosclerosis and tubulointerstitial injury, as described previously. 22, 23 For the detailed method of how to calculate the glomerular and tubulointerstitial scores, please see the online Data Supplement. All of the morphometric measurements were performed by 2 examiners (H.K. and H.S.), who were blinded to the treatment protocol.
Statistical Analysis
All of the values were presented as meanϮSEM. In the acute ICV administration experiments (Figures 2 and 3 ), the baseline value was defined as the mean value over a 1-minute stabilization period before the administration of drugs, and the peak value was defined as a mean value for 10 seconds around the maximum response. The magnitude of the changes was expressed as the percentage of change between the peak and the baseline values. In addition, to evaluate the magnitude and time course responses to hexamethonium ( Figure S1 , available in the online Data Supplement) and ICV Tempol ( Figure  S2 ), the area under the curve was calculated (please see the online Data Supplement). Dunnett test was used for comparisons between the UnxϩHS rats and the other groups of rats, and it was performed with JMP 9.0.0 (SAS Institute, Cary, NC) computer software. P values of PϽ0.05 were considered to indicate statistical significance.
Results

Effects of Salt Loading and Uninephrectomy on Brain ROS-Mediated Sympathetic Nerve Activity, Blood Pressure, and Renal Function in Young Sprague-Dawley Rats
Response of MAP to Ganglionic Blockade With Hexamethonium Hydrochloride
The MAP reduction induced by hexamethonium was significantly greater in the UnxϩHS rats than in the other 3 groups of rats (UnxϩHS: Ϫ102.1Ϯ10.0 versus sham: Ϫ40.5Ϯ3.5, shamϩHS: Ϫ44.3Ϯ1.5, Unx: Ϫ 45.8Ϯ3.3 mm Hg; PϽ0.001, respectively; Figure 1A ), which suggests that sympathetic activity increased significantly in the UnxϩHS rats. Area under the curve elicited similar results ( Figure S1 ).
Blood Pressure
The SBP was significantly elevated in the UnxϩHS rats compared with the other 3 groups of rats (UnxϩHS: 196.6Ϯ10. 
Effects of Acute ICV Tempol on RSNA, MAP, and HR
Integrated RSNA, MAP, and HR started decreasing a few minutes after ICV Tempol administration and reached their lowest levels within Ϸ15 minutes (RSNA and MAP; Figure 2 ). The reduction in RSNA was significantly greater in the UnxϩHS rats (UnxϩHS: Ϫ13.0Ϯ2.6% versus sham: Ϫ2.9Ϯ0.7%; Pϭ0.004, shamϩHS: Ϫ1.8Ϯ1.3%; Pϭ0.001, Unx: Ϫ5.2Ϯ1.7%; Pϭ0.024; Figure 3A) . Likewise, the reduction in MAP was significantly greater in the UnxϩHS rats than in the other 3 groups of rats (UnxϩHS: Ϫ28.9Ϯ2.4% versus sham: Ϫ5.7Ϯ1.7%, shamϩHS: Ϫ7.0Ϯ2.3%, Unx: Ϫ7.3Ϯ2.6%; PϽ0.001, respectively; Figure 3B ). In a similar fashion, the reduction in HR was significantly greater in the UnxϩHS rats (UnxϩHS: Ϫ13.6Ϯ2.9% versus sham: Ϫ1.3Ϯ1.6%; Pϭ0.003, shamϩHS: Ϫ0.5Ϯ0.6%; Pϭ0.001, Unx: Ϫ1.5Ϯ2.4%; Pϭ 0.003; Figure 3C ). Area under the curve elicited similar results ( Figure S2 ).
Measurement of NADPH-Induced Superoxide Production in the Isolated Hypothalamus
NADPH-induced superoxide production significantly increased in the isolated hypothalamus of the UnxϩHS rats compared with the other 3 groups of rats (UnxϩHS: 2.5Ϯ0.2ϫ10 6 Figure 4 ).
Urinary Protein Excretion and Renal Histology
Compared with the other 3 groups of rats, the UnxϩHS rats had significantly higher urinary protein excretion levels (UnxϩHS: 162. 
Effect of Chronic Oral Moxonidine on Sympathetic Nerve Activity, Blood Pressure, and Renal Function in Salt-Induced CKD Rats
Chronic oral moxonidine resulted in sympathoinhibitory, depressor, and renoprotective effects in the UnxϩHS rats, the 
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salt-induced CKD model. The MAP reduction induced by hexamethonium was inhibited (Ϫ75.5Ϯ1.7 mm Hg; Pϭ0.012; Figure 1A ) in the UnxϩHSϩMox rats. Figure 1B ). The UnxϩHSϩMox rats also showed decreased proteinuria (10.4Ϯ2.3 mg/d; PϽ0.001; Figure 5A ) and improved glomerular (0.2Ϯ0.0; PϽ0.001; Figure 5C ) and tubulointerstitial scores (0.3Ϯ0.1; PϽ0.001; Figure 5C ) compared with the untreated UnxϩHS rats. Hypothalamic NADPH-induced superoxide production in the UnxϩHSϩMox rats (1.9Ϯ0.2ϫ10 6 RLU/10 min per gram; Nϭ5) did not significantly decrease (Pϭ0.212) compared with the untreated UnxϩHS rats.
Effect of Chronic ICV Tempol on Sympathetic
Nerve Activity, Blood Pressure, and Renal Function in Salt-Induced CKD Rats
As mentioned above, a central sympatholytic agent, moxonidine, showed depressor and renoprotective effects, which suggests that central sympathoexcitation is involved in the arterial pressure elevation and the resultant progression of CKD in the UnxϩHS rats. Subsequently, the effect of treatment with chronic ICV Tempol on sympathetic nerve activity, blood pressure, and renal function was evaluated in the UnxϩHS rats to determine whether sympathoexcitation by continuously increased brain oxidative stress mediates arterial pressure elevation and renal injury. Hypothalamic NADPH-induced superoxide production decreased significantly in the UnxϩHSϩICV temp rats (1.5Ϯ0.1ϫ10 Figure 1B) . The UnxϩHSϩICV temp rats also showed decreased proteinuria (13.7Ϯ1.9 mg/d; PϽ0.001; Figure 5A ) and improved glomerular (0.3Ϯ0.0; PϽ0.001; Figure 5B and 5C) and tubulointerstitial scores (0.5Ϯ0.1; PϽ0.001; Figure 5B 
Discussion
In the present study, uninephrectomy and salt loading from a young age in rats resulted in arterial pressure elevation and the progression of renal damage and were associated with sympathoexcitation. Importantly, we have demonstrated 2 major findings suggesting brain ROS-mediated sympathoexcitation and the resultant blood pressure elevation in the above-mentioned salt-induced CKD rats. First, the acute ICV antioxidant infusion experiment suggests that brain ROS stimulates sympathetic nerve activity, leading to hypertension in the salt-induced CKD rats, in a manner similar to the hypertension models in our previous studies [17] [18] [19] ; reductions in RSNA, MAP, and HR elicited by acute ICV administration of the antioxidant Tempol and hypothalamic NADPHinduced ROS were significantly greater in the UnxϩHS rats (Figures 2-4) . Second, the chronic ICV antioxidant infusion experiment suggests that the overproduction of brain ROS contributes to arterial pressure elevation through sympathoexcitation; chronic ICV Tempol normalized sympathetic nerve activity and arterial pressure (Figure 1 ). Moreover, oral moxonidine, a central sympatholytic agent, elicited similar effects ( Figure 1 ). These results suggest that central sympathoexcitation via brain oxidative stress leads to arterial pressure elevation in salt-induced CKD. Our viewpoint that oxidative stress in the brain causes central sympathoexcitation in the salt-induced CKD rats is plausible, because recent studies, including ours, [17] [18] [19] have suggested that oxidative stress overproduction in the brain activates the sympathetic nervous system. For example, the Figure 4 . Reduced NADPH-dependent superoxide anion production assessed by lucigenin chemiluminescence in the isolated hypothalamic sections from sham, shamϩHS, Unx, and UnxϩHS rats. The chemiluminescence value was significantly higher in UnxϩHS rats than in the control rats (sham, shamϩHS, and Unx). Data are represented as meanϮSEM. RLU indicates relative light units. Abbreviations for rats are as follows: sham-operated rats raised with a normal (sham) or high-salt diet (shamϩHS), uninephrectomized rats raised with a normal (Unx) or high-salt diet (UnxϩHS Figure 5 . A, Twenty-four-hour urinary protein excretion in sham, shamϩHS, Unx, UnxϩHS, UnxϩHSϩMox, and UnxϩHSϩICV temp rats. Significantly higher proteinuria was elicited in UnxϩHS rats than in the control rats (sham, shamϩHS, and Unx) or the UnxϩHSϩMox and UnxϩHSϩICV temp rats. B, Representative photomicrographs of the glomerulus (magnification, ϫ200, top) and tubulointerstitial area (ϫ50, bottom) of the kidney in Unx, UnxϩHS, and UnxϩHSϩICV temp rats after staining with the periodic acid-Schiff (PAS) stain. C, The glomerular (top) and tubulointerstitial scores (bottom) in sham, shamϩHS, UNx, UNxϩHS, UnxϩHSϩMox, and UnxϩHSϩICV temp rats. Significantly greater glomerular and interstitial damage was elicited in UnxϩHS rats; this damage was reversed to almost normal levels by oral moxonidine and ICV Tempol administration. Data are represented as meanϮSEM. Abbreviations for rats are as follows: shamoperated rats raised with a normal (sham) or high-salt diet (shamϩHS), uninephrectomized rats raised with a normal (Unx) or high-salt diet (UnxϩHS), moxonidine-treated UnxϩHS rats (UnxϩHSϩMox), and chronic ICV Tempol-treated UnxϩHS rats (UnxϩHSϩICV temp).
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microinjection of Tempol into the dorsomedial hypothalamus 38 or the rostral ventrolateral medulla (RVLM) 39 attenuated sympathoexcitatory responses to emotional stress in rabbits. ICV infusion of antioxidants, including in the present study, elicited a sympathoinhibitory effect, suggesting that oxidative stress directly stimulates central sympathetic nerve activity. 18, 19, 40 In stroke-prone spontaneously hypertensive rats, the level of ROS was higher in the RVLM, and manganese superoxide dismutase overexpression in the RVLM decreased sympathetic nerve activity. 41 Thus, brain ROS overproduction may induce central activation of the sympathetic nervous system. In the present study, we showed that sympathetic inhibition by central antioxidant treatment with chronic ICV Tempol normalized arterial pressure, which, in turn, led to a reduction in renal damage. Thus, it is suggested that sympathoexcitation by brain oxidative stress mediates arterial pressure elevation in some types of hypertension that are associated with salt retention and renal injury, both of which are associated with salt-sensitive and obesity-induced hypertension and CKD. In fact, chronic ICV Tempol significantly decreased brain ROS in the UnxϩHS rats (Figure 4 ). In addition, because continuous oral administration of moxonidine improved hypertension and alleviated renal damage despite unchanged levels of brain ROS, sympathetic inhibition did not reduce brain ROS levels; instead, brain ROS would appear to be an upstream element governing central sympathoexcitation in salt-induced CKD rats. Because several investigators have reported that the peripheral administration of Tempol decreases blood pressure and ameliorates renal function in rats with hypertension and CKD, [22] [23] [24] someone may speculate that leakage of Tempol into the peripheral vasculature causes depressor and renoprotective effects in the UnxϩHS rats. However, the data from the present study do not support this speculation, because the peripheral administration of Tempol at the same dose as ICV-administered Tempol did not exert any hypotensive or renoprotective effects. The dose of Tempol used in the present study was apparently lower than that used in reports that showed the depressor and renoprotective effects of peripherally administered Tempol. [22] [23] [24] Thus, the central antioxidant effect must play a major role in the depressor effect via sympathetic inhibition by central ICV Tempol.
In CKD, renal injury may activate afferent pathways, which project to the central cardiovascular region in the brain and regulate arterial pressure through the efferent sympathetic nerve. 1, [12] [13] [14] Our findings are compatible with the possibility that the renal afferent nerve can increase brain oxidative stress, leading to arterial pressure elevation through sympathoexcitation. These findings support other reports showing brain ROS overproduction in the phenol renal injury model of hypertension 27 and the 2-kidney, 1-clip hypertension model. 28 ICV administration can act in the hypothalamic area, which is supposed to contain several nuclei critically involved in the cardiovascular regulation system, such as the subfornical organ, paraventricular hypothalamic nuclei, and organum vasculosum of the stria terminalis. Other regions of the brain, such as the RVLM, 28, 41 have also been recognized as key areas that can mediate oxidative stress-induced sympathoexcitation. In contrast, previous studies that used ICV infusion of antioxidants, including those in our laboratory, suggest that the hypothalamus is a critical area for ROS generation and the maintenance of sympathetic control of the cardiovascular system. 17, 18, 27, 35, 42, 43 These results are compatible with the present data, although the region-related functions of the brain are complicated and remain unknown.
Although the present study has demonstrated that central oxidative stress-induced sympathoexcitation could mediate hypertension, the potential mechanisms underlying the increase in brain oxidative stress in CKD remain unclear. Several studies have shown that a centrally administered angiotensin II has a sympathoexcitatory effects, possibly by generating oxidative stress. 39, 43, 44 Furthermore, the brain renin-angiotensin system was upregulated in rats with chronic renal failure. 45 Therefore, the renin-angiotensin system in the brain may stimulate the generation of central oxidative stress associated with renal dysfunction. Moreover, brain aldosterone and mineralocorticoid receptors, which are stimulated by the renin-angiotensin system, can also be involved in central oxidative stress-induced sympathoexcitation. Aldosterone acts centrally to increase brain oxidative stress. 33 Furthermore, hypothalamic aldosterone levels are increased by salt loading. ICV aldosterone synthase inhibitor, as well as a mineralocorticoid receptor blocker, can prevent salt-induced hypertension in Dahl salt-sensitive rats. 46 The blockade of central mineralocorticoid receptors also improved saltinduced left-ventricular systolic dysfunction through attenuation of sympathoexcitation in pressure-overload model mice. 47 Thus, aldosterone and mineralocorticoid receptors may contribute to the overproduction of central oxidative stress overproduction, resulting in sympathoexcitationinduced hypertension. On the other hand, any abnormality in NO synthase 48, 49 or the superoxide-scavenging system, such as extracellular superoxide dismutase 50 in the central nervous system, might contribute to the upregulation of brain oxidative stress.
Although we focused on brain ROS as a mechanism of sympathoexcitation in salt-induced CKD in the present study, central mechanisms other than ROS in the brain could play important roles in the sympathetic regulation of arterial pressure. For example, a simple reduction in dietary salt intake revealed a tonic sustaining effect of angiotensin II in the RVLM, leading to an increase in RSNA. 51 Further study is needed to clarify the precise mechanisms underlying sympathoexcitation in hypertension associated with CKD.
In the present study, sympathoexcitation, in addition to hypertension and renal dysfunction, was confirmed in the UnxϩHS rats, and the reductions in RSNA, MAP, and HR levels elicited by acute ICV administration of the antioxidant Tempol and hypothalamic NADPH-induced ROS were significantly greater in the UnxϩHS rats than in the control rats. Furthermore, chronic ICV Tempol normalized sympathetic nerve activity and then normalized arterial pressure, which, in turn, led to a reduction in renal damage. In conclusion, these findings suggest that, in salt-induced CKD, sympathoexcitation by increased oxidative stress in the brain may mediate arterial pressure elevation.
Perspectives
Hypertension associated with CKD, a highly predisposing condition for cardiovascular disease, requires appropriate management. However, the detailed pathological mechanisms have not been fully elucidated. In CKD subjects, high salt intake increases blood pressure and causes a greater degree of renal damage than in CKD-free subjects. In the present study, we have demonstrated that sympathoexcitation via oxidative stress in the brain may mediate arterial pressure elevation in salt-induced CKD rats. Salt-sensitive 18 and obesity-induced 19 hypertension, in which the brain ROS increases blood pressure through sympathoexcitation, also tends to be associated with CKD. Therefore, our series of findings suggest that sympathoexcitation via brain oxidative stress could be a common mechanism for the rise in blood pressure associated with salt-sensitive and obesity-induced hypertension and CKD. Sympathoexcitation has been reported to lead to cardiovascular events, in addition to the development of renal dysfunction and hypertension, in CKD patients, 5, 52 and it is directly related to a patient's prognosis. 53 Based on our new insights, a novel strategy, such as the administration of a blood-brain barrier-permeable antioxidant agent with a sympathoinhibitory effect, may be useful for preventing and managing not only hypertension but also cardiovascular events in CKD patients.
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RSNA data were fed into a personal computer after analog-to-digital conversion (Power Lab, ADInstrument, Castle Hill, NSW, Australia), together with data on arterial pressure, heart rate and timing pulses of drug administration, and analyzed by signal analysis software (Chart, ADInstrument). 
Urinary Protein Excretion and Renal Histology
